138 related articles for article (PubMed ID: 35491151)
1. [Role of Fatty Acid Elongase Elovl6 in the Regulation of Fatty Acid Quality and Lifestyle-related Diseases].
Matsuzaka T; Shimano H
Yakugaku Zasshi; 2022; 142(5):473-476. PubMed ID: 35491151
[TBL] [Abstract][Full Text] [Related]
2. Role of fatty acid elongase Elovl6 in the regulation of energy metabolism and pathophysiological significance in diabetes.
Matsuzaka T
Diabetol Int; 2021 Jan; 12(1):68-73. PubMed ID: 33479581
[TBL] [Abstract][Full Text] [Related]
3. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
[TBL] [Abstract][Full Text] [Related]
4. Elovl6: a new player in fatty acid metabolism and insulin sensitivity.
Matsuzaka T; Shimano H
J Mol Med (Berl); 2009 Apr; 87(4):379-84. PubMed ID: 19259639
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.
Yew Tan C; Virtue S; Murfitt S; Roberts LD; Phua YH; Dale M; Griffin JL; Tinahones F; Scherer PE; Vidal-Puig A
Sci Rep; 2015 Dec; 5():18366. PubMed ID: 26679101
[TBL] [Abstract][Full Text] [Related]
7. Elovl6 promotes nonalcoholic steatohepatitis.
Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
[TBL] [Abstract][Full Text] [Related]
8. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
9. Ablation of Elovl6 protects pancreatic islets from high-fat diet-induced impairment of insulin secretion.
Tang N; Matsuzaka T; Suzuki M; Nakano Y; Zao H; Yokoo T; Suzuki-Kemuriyama N; Kuba M; Okajima Y; Takeuchi Y; Kobayashi K; Iwasaki H; Yatoh S; Takahashi A; Suzuki H; Sone H; Shimada M; Nakagawa Y; Yahagi N; Yamada N; Shimano H
Biochem Biophys Res Commun; 2014 Jul; 450(1):318-23. PubMed ID: 24938128
[TBL] [Abstract][Full Text] [Related]
10. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
[TBL] [Abstract][Full Text] [Related]
11. Advanced Oxidation Protein Products Contribute to Renal Tubulopathy
Imafuku T; Watanabe H; Satoh T; Matsuzaka T; Inazumi T; Kato H; Tanaka S; Nakamura Y; Nakano T; Tokumaru K; Maeda H; Mukunoki A; Takeo T; Nakagata N; Tanaka M; Matsushita K; Tsuchiya S; Sugimoto Y; Shimano H; Fukagawa M; Maruyama T
Kidney360; 2020 Aug; 1(8):781-796. PubMed ID: 35372949
[TBL] [Abstract][Full Text] [Related]
12. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance.
Sun H; Jiang T; Wang S; He B; Zhang Y; Piao D; Yu C; Wu N; Han P
Diabetes Res Clin Pract; 2013 Dec; 102(3):183-92. PubMed ID: 24262945
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in the ELOVL6 gene is associated with a major QTL effect on fatty acid composition in pigs.
Corominas J; Ramayo-Caldas Y; Puig-Oliveras A; Pérez-Montarelo D; Noguera JL; Folch JM; Ballester M
PLoS One; 2013; 8(1):e53687. PubMed ID: 23341976
[TBL] [Abstract][Full Text] [Related]
14. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout.
Shimano H
Prog Lipid Res; 2012 Jul; 51(3):267-71. PubMed ID: 22266797
[TBL] [Abstract][Full Text] [Related]
15. Two modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycle.
Naganuma T; Kihara A
PLoS One; 2014; 9(7):e101823. PubMed ID: 25003994
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N
Nat Med; 2007 Oct; 13(10):1193-202. PubMed ID: 17906635
[TBL] [Abstract][Full Text] [Related]
17. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic β-cells by stearoyl-CoA desaturase and Elovl6.
Green CD; Olson LK
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E640-9. PubMed ID: 21266672
[TBL] [Abstract][Full Text] [Related]
18. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.
Tan CY; Virtue S; Bidault G; Dale M; Hagen R; Griffin JL; Vidal-Puig A
Cell Rep; 2015 Dec; 13(10):2039-47. PubMed ID: 26628376
[TBL] [Abstract][Full Text] [Related]
19. The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.
Laggai S; Kessler SM; Boettcher S; Lebrun V; Gemperlein K; Lederer E; Leclercq IA; Mueller R; Hartmann RW; Haybaeck J; Kiemer AK
J Lipid Res; 2014 Jun; 55(6):1087-97. PubMed ID: 24755648
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Wang Y; Botolin D; Xu J; Christian B; Mitchell E; Jayaprakasam B; Nair MG; Peters JM; Busik JV; Olson LK; Jump DB
J Lipid Res; 2006 Sep; 47(9):2028-41. PubMed ID: 16790840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
